Luminex to Streamline Tyson’s Food Safety Network
As Tyson Food’s Richard Bond led an initiative to cut costs and improve earnings, he no doubt eyed the costly but necessary food safety and […]
Articles by Doug Cress
NovaDel NDA: Longs May Finally Get a Good Night’s Sleep
The FDA has accepted Flemington, NJ-based NovaDel Pharma’s New Drug Application for ZolpiMist. ZolpiMist is an oral spray for the short-term treatment of insomnia. The […]
Nanomaterial Coatings Help Drugs Bypass Bodily Defenses
A new study published in the January issue of ACS Nano offers insight into cutting edge world of drug delivery research. In the study, UCLA […]
Laser Battles Reach Fever Pitch
A quick glance at the Diomed’s recent press releases might lead you to believe the company is a law firm, rather than a provider of […]
FDA Puts Brakes on Expanded Indication for PreMD’s Skin Sterol Diagnostic
Company to decrease spending to ensure its ability to execute. Tortono, Ontario-based PreMD received a non-substantially equivalent letter from the FDA regarding its 510(k) submission […]
New Study Highlights Promising Gene-Based Predictor of Prostate Cancer Risk
Test to be commercialized by Proactive Genomics, LLC In the past few years, novel research tools have emerged which scientist to systematically and objectively evaluate […]
Private Equity Firm Warburg Pincus to Acquire Lifecore Biomedical
Even as access to cheap debt has dried up and the rate of deals flow has dwindled, Warburg Pincus seems to show no sign of […]
Novo Nordisk Loses Faith in AERx, Takes a $260 Million Hit
Denmark-based Novo Nordisk discontinued its experimental AERx insulin inhaler triggering a hefty one-time charge of $260 million. Novo, the world’s biggest insulin producer, said that […]
CryoLife: Weak in the Knees
Company Pinpoints “Untrue Public Statements” in $110 million Lawsuit CryoLife’s legal problems began when tissue from CryoLife-processed donor tissue led to the November 2001 death […]
MelaFinding Its Way
Irvington-NY based Electro-Optical Sciences (EOS), developer of The MelaFind System, a handheld imaging device that detects melanomas at an early stage, announced last week that […]